CDRH Prioritizes Point of Care Serology Test EUAs

Jun 15, 2020 Washington, D.C.,

By: Jessica Wasserman, Esq.

On June 10th, we participated on a call hosted by the U.S. Food and Drug Administration Center for Devices and Radiological Health (CDRH) to provide updates on CDRH policies and practices of interest to clinical laboratories and commercial manufacturers that are developing or have developed diagnostic and antibody tests for SARS-CoV-2.

CDRH announced that it is now prioritizing Point Of Care antibody/serology test EUA authorizations. This is an important change because POC testing is what is needed for significantly increasing the number of people tested for antibodies and the country moves to return to work and to school.

At present, of the 96 EUAs authorized, only 3 so far have been authorized to be administered at Point of Care; and of these none are for antibody/serology tests. This means that it is not possible to widely distribute serology antibody tests until CDRH begins authorizing for POC.

To assist developers and manufacturers through the EUA authorization process, FDA has issued a number of “templates” to follow to submit a successful authorization request. FDA has not yet published a template for POC, but announced that it will soon do so:

Molecular Diagnostic Template for Manufacturers (Updated May 13, 2020)
Molecular Diagnostic Template for Laboratories (Updated May 13, 2020)
Serology Template for Manufacturers (unchanged from May 4, 2020)
Serology Template for Laboratories (unchanged from May 4, 2020)
Antigen Template for Manufacturers (May 11, 2020)
Home Specimen Collection Molecular Diagnostic Template (May 29, 2020)

About Greenspoon Marder

Greenspoon Marder LLP is a full-service law firm with over 225 attorneys and more than 20 office locations across the United States. With operations from Miami to New York and from Denver to Los Angeles, our firm attracts some of the nation’s top talent in key markets and innovation hubs. Our core practice areas include Real Estate, Litigation, and Transactional Services, complemented by the capabilities of a full-service firm. Greenspoon Marder has maintained a spot on The American Lawyer’s Am Law 200 as one of the top law firms in the U.S. since 2015, and our goal is to provide exceptional client service by developing a thorough understanding of each client’s business needs and objectives in order to provide strategic, cost-effective solutions.

MEDIA CONTACT

Natalie Villanueva, Director of Marketing
954.333.4308 | [email protected]

This Greenspoon Marder LLP Client Alert is issued for informational purposes only and is not intended to be construed or used as general legal advice nor a solicitation of any type. Please contact the author(s) or your Greenspoon Marder LLP contact if you have any questions regarding the currency of this information. The hiring of a lawyer is an important decision. Before you decide, ask for written information about the lawyer’s legal qualifications and experience.

Previous Next

News

CDRH Prioritizes Point of Care Serology Test EUAs

Share

News & Events

News & Events